Clinical progression: need for NIV, IMV, ECMO, or renal replacement therapy at day 5 (group 5, 6 or 7) · hospitalised individuals with COVID‐19 (moderate to severe disease)
It is very uncertain whether bamlanivimab changes clinical progression: need for NIV, IMV, ECMO, or renal replacement… compared with placebo (very low certainty).
1 finding from 1 review
Failure of therapy · Children and/or adults with permanent or primary teeth, vital (sensitive) pulps, and cavitated or dentine carious lesions conventionally…
It is very uncertain whether hall Technique (sealing with a preformed metal crown) changes failure of therapy compared with non-restorative cavity control (NRCC) (very low certainty).
1 finding from 1 review
Failure of therapy · Children and/or adults with permanent or primary teeth, vital (sensitive) pulps, and cavitated or dentine carious lesions conventionally…
It is very uncertain whether non-selective carious tissue removal and conventional restoration (CR) changes failure of therapy compared with non-restorative cavity control (NRCC) (very low certainty).
1 finding from 1 review
Failure of therapy · Children and/or adults with permanent or primary teeth, vital (sensitive) pulps, and cavitated or dentine carious lesions conventionally…
It is very uncertain whether sealing using sealant materials changes failure of therapy compared with non-selective carious tissue removal and conventional restoration (CR) (very low certainty).
1 finding from 1 review
Failure of therapy · Children and/or adults with permanent or primary teeth, vital (sensitive) pulps, and cavitated or dentine carious lesions conventionally…
It is very uncertain whether sealing using sealant materials changes failure of therapy compared with no treatment (very low certainty).
1 finding from 1 review
Relapse · SSNS in children
It is very uncertain whether levamisole changes relapse: at end of therapy compared with cyclophosphamide (very low certainty).
4 findings from 1 review
RR 2.14 [0.22, 20.95]
2 studies · 97 participants
Very low
RR 1.17 [0.76, 1.81]
2 studies · 97 participants
Low
RR 0.89 [0.68, 1.16]
1 study · 40 participants
Low
Show 1 more finding
Relapse at end of therapy (6 to 9 months) · SSNS in children
Alkylating agents showed no clear difference in relapse at end of therapy (6 to 9 months) compared with cyclosporin (low certainty).
1 finding from 1 review
Mean number of wet nights a week · children with nocturnal enuresis
1 finding from 1 review
Proportion of children achieving 14 consecutive dry nights by the end of treatment · children with nocturnal enuresis
It is very uncertain whether alarm changes proportion of children achieving 14 consecutive dry nights by the… compared with miscellaneous treatments (very low certainty).
3 findings from 1 review
RR 0.84 [0.55, 1.29]
1 study · 39 participants
Very low
RR 3.62 [1.38, 9.5]
2 studies · 116 participants
Very low
RR 3 [1.41, 6.39]
1 study · 96 participants
Very low
Need for extra treatment · Patients with quiescent ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for extra treatment · Patients with quiescent ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for extra treatment · Patients with quiescent ulcerative colitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Thermal therapy VAS (0 to 10 cm) · uraemic pruritus
1 finding from 1 review
Intervention not reported
Intolerance to therapy ‐ Gastrointestinal intolerance · people with CKD requiring dialysis
The intervention showed no clear difference in intolerance to therapy ‐ Gastrointestinal intolerance (low certainty).
1 finding from 1 review
Proportion of infants receiving any pharmacotherapy for a hemodynamically significant PDA · preterm infants
Early treatment may leads to higher proportion of infants receiving any pharmacotherapy for a… compared with expectant management (low certainty).
1 finding from 1 review
Proportion of infants receiving any pharmacotherapy for a hemodynamically significant PDA · preterm infants
It is very uncertain whether very early treatment changes proportion of infants receiving any pharmacotherapy for a… compared with expectant management (very low certainty).
1 finding from 1 review
Adherence · pregnant and postpartum women with HIV
Digital targeted client communication via mobile devices may leads to higher health behaviour change: adherence to ARV therapy compared with standard care or no intervention (pregnant and postpartum women with… (low certainty).
1 finding from 1 review
Adherence · pregnant and postpartum women with HIV
1 finding from 1 review
Adherence · pregnant and postpartum women with HIV
Digital targeted client communication via mobile devices may leads to higher health behaviour change: adherence to ARV therapy compared with digital non‐targeted client communication (pregnant and postpartum… (low certainty).
1 finding from 1 review
Intervention not reported
Requirement for renal replacement therapy ( · adult (≥ 18 years of age) patients receiving mechanical ventilation (via either an endotracheal tube or a tracheostomy) for acute…
It is very uncertain whether the intervention changes requirement for renal replacement therapy ( (very low certainty).
1 finding from 1 review